Traditionally, T2D pathophysiology was framed by dysfunction within pancreatic islets—namely, insulin-secreting β-cells and glucagon-secreting α-cells—as well as insulin-responsive tissues, such as skeletal muscle, adipose tissue, and the liver [2]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.